Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis

Basit Öğe Kaydı
dc.authoridŞenol Kobak / 0000-0001-8270-640Xen_US
dc.authorscopusidŞenol Kobak / 12782228700
dc.authorwosidŞenol Kobak / AAO-2482-2020
dc.contributor.authorGediz, Füsun
dc.contributor.authorUğur, Mehmet Can
dc.contributor.authorTürkmen, Meltem
dc.contributor.authorKobak, Şenol
dc.date.accessioned2021-03-15T11:35:53Z
dc.date.available2021-03-15T11:35:53Z
dc.date.issued2021en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractAbstract Psoriatic arthritis (PsA) is a chronic inflammatory disease characterized by skin and joint involvement. The disease may present with various joint pattern involvement, which sometimes may lead to joint destruction and deformity. Early diagnosis and treatment with disease-modifying anti-rheumatic drugs may prevent joint deformity. Recently there are many new treatment options including biologic drugs. Ustekinumab, an interleukin 12/23 inhibitor, has proven efficacy in the treatment of psoriatic arthritis. Like other biologic drugs (anti-TNF-?), there are contradictory data about the safety of ustekinumab and possible relationship with cancer development. Herein we report the development of chronic lymphocytic leukemia in a patient with PsA treated with ustekinumab.en_US
dc.identifier.citationGediz, F., Ugur, M. C., Turkmen, M., & Kobak, S. (2021). Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis. Reumatologia, 59(1), 58–61. https://doi.org/10.5114/reum.2021.102618en_US
dc.identifier.doi10.5114/reum.2021.102618en_US
dc.identifier.endpage61en_US
dc.identifier.issue1en_US
dc.identifier.pmid33707797en_US
dc.identifier.scopus2-s2.0-85103056904en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage58en_US
dc.identifier.urihttps://doi.org/10.5114/reum.2021.102618
dc.identifier.urihttps://hdl.handle.net/20.500.12713/1568
dc.identifier.volume59en_US
dc.identifier.wosWOS:000625304900010en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorKobak, Şenol
dc.language.isoenen_US
dc.publisherPMCen_US
dc.relation.ispartofReumatologiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChronic Lymphocytic Leukemiaen_US
dc.subjectPsoriatic Arthritisen_US
dc.subjectUstekinumaben_US
dc.titleUstekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritisen_US
dc.typeReview Articleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
33.pdf
Boyut:
109.88 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

PubMed İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu